Definitive Contract 75N91018C00033
Award Date
9/17/18
Potential Completion Date
3/16/20
Potential Value
$300K
Federal Agency
National Cancer Institute
Awardee
Electronic Biosciences, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract for $248,077.00 awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Electronic Biosciences, Inc., a for-profit organization located in San Diego, CA. The contract is for the development of nanoscale tools for RNA modification sequencing. Electronic Biosciences has previously received federal grants and contracts from...
This federal contract award was made by the National Institute of Standards and Technology (NIST), a civilian agency, to Electronic Biosciences, Inc., a small business biotechnology company. The $299,973.23 contract is a Small Business Innovation Research (SBIR) Phase II award under the American Recovery and Reinvestment Act (ARRA) to fund the development of Electronic Biosciences' advanced nanopore-based sequencing and analytical technologies. This definitive, firm-fixed price contract supports...
<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
This is a $270,284.00 Firm Fixed Price Definitive Contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Biospyder Technologies, Inc., a small business manufacturer of genomic analysis services and products. The contract was awarded under the Small Business Innovation Research (SBIR) Phase I program for Topic 353: CFNA TEMPO-SEQ ASSAY, with a completion date of June 18, 2017. Biospyder provides next-generation sequencing,...
This definitive firm fixed price contract was awarded by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, to Digital Nanogenetics LLC on September 17, 2018. With a potential value of $300,000, the contract is associated with the Small Business Innovation Research Program Phase I and has a completion date of September 19, 2019. The contract has a set aside designation for total small businesses and will support research...
This firm fixed price BPA Call order from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, is valued at twenty-four thousand eight hundred fifty-seven dollars and eighty-four cents ($24,857.84). Prime contractor 10X Genomics, Inc. will provide single cell kits to the Chen Lab members at its Pleasanton, California location for use in single-cell analysis and research from November 16, 2022 through December 15, 2022. ...
This federal contract award, valued at $249,990.00, was issued by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services. The prime contractor is 10X Genomics, Inc., a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The award is for the delivery of six (6) Chromium Next GEM Single Cell Multiome ATAC and Gene Expression Reagent...
This federal contract award is for the supply and installation of a Sequel II DNA sequencing machine by Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment. The contract, valued at $522,500.00, was awarded on May 13, 2019 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations. The contract is a firm-fixed price purchase order with a completion date of June 9, 2019. Pacific...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $63,600 firm fixed price purchase order to Pacific Biosciences of California, Inc. for COMP. SEQUEL II SRV CONTRACT W/O INSIGHT. As the award references sequencing services without insight, it can be inferred the contract is to provide next generation DNA sequencing capabilities to support NIH research initiatives. Pacific Biosciences will perform the sequencing work...
This is a $24,999 firm fixed price contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Nanostring Technologies, Inc., a publicly traded provider of specialized genomic analysis equipment and services. The contract is a BPA call, indicating it was issued under a larger Blanket Purchase Agreement. Nanostring will provide the agency with its proprietary nCounter Analysis Systems, GeoMx Digital Spatial Profilers, custom gene expression panels, and related...